Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biora Therapeutics (BIOR)
OTHER OTC:BIOR
Holding BIOR?
Track your performance easily
BIOR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.26 - $19.90
Previous Close$0.6
Volume105.83K
Average Volume (3M)130.50K
Market Cap
$2.71M
Enterprise Value$21.58M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$18.87M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Mar 26, 2025EPS Estimate
-$3.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-13.03
Shares Outstanding4,522,702
10 Day Avg. Volume307,308
30 Day Avg. Volume130,499
Standard Deviation0.34
R-Squared0.02
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)-0.03
Price to Sales (P/S)3.04
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.20
Enterprise Value/Gross Profit5.40K
Enterprise Value/Ebitda-0.28
Forecast
1Y Price Target
$23.00Price Target Upside3733.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Biora Therapeutics News
PremiumCompany Announcements
Biora Therapeutics Faces Nasdaq Delisting Challenges
PremiumCompany Announcements
Biora Therapeutics Reports Q3 2024 Results and Updates
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIOR FAQ
What was Biora Therapeutics’s price range in the past 12 months?
Biora Therapeutics lowest stock price was $0.26 and its highest was $19.90 in the past 12 months.
What is Biora Therapeutics’s market cap?
Currently, no data Available
When is Biora Therapeutics’s upcoming earnings report date?
Biora Therapeutics’s upcoming earnings report date is Mar 26, 2025 which is in 94 days.
How were Biora Therapeutics’s earnings last quarter?
Biora Therapeutics released its earnings results on Nov 14, 2024. The company reported -$6.08 earnings per share for the quarter, missing the consensus estimate of -$3.85 by -$2.23.
Is Biora Therapeutics overvalued?
According to Wall Street analysts Biora Therapeutics’s price is currently Undervalued.
Does Biora Therapeutics pay dividends?
Biora Therapeutics does not currently pay dividends.
What is Biora Therapeutics’s EPS estimate?
Biora Therapeutics’s EPS estimate is -$3.5.
How many shares outstanding does Biora Therapeutics have?
Biora Therapeutics has 4,522,702 shares outstanding.
What happened to Biora Therapeutics’s price movement after its last earnings report?
Biora Therapeutics reported an EPS of -$6.08 in its last earnings report, missing expectations of -$3.85. Following the earnings report the stock price went down -4.418%.
Which hedge fund is a major shareholder of Biora Therapeutics?
Currently, no hedge funds are holding shares in BIOR
---
Biora Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$23.00 (3733.33% Upside)
$23.00 (3733.33% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.02%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-58.20%
Trailing 12-Months
Company Description
Biora Therapeutics
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
---
BIOR Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant advancements in clinical trials and partnerships, especially for the NaviCap and BioJet platforms, alongside strong financial backing from investors. However, the company faces operational challenges with legacy costs and high operating expenses.Read More>---
BIOR Stock 12 Month Forecast
Average Price Target
$23.00
▲(3733.33% Upside)
Best Analysts Covering BIOR
1 Year
1 Year Success Rate
0/9 ratings generated profit
1 Year Average Return
-85.64%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -85.64% per trade.
---